SelectX Pharmaceuticals logo — company profile

SelectX Pharmaceuticals

Founded 2002 United States Worcester, United States 6 employees Series B Total: $8.00M Biotechnology, Health Care +1

General Information

Company Name SelectX Pharmaceuticals
Founded Year 2002
Location United States Worcester, United States +1
Employees 6
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series B
Social

Get notified when SelectX Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About SelectX Pharmaceuticals

SelectX Pharmaceuticals is a biopharmaceutical company founded in 2002 and headquartered in the United States. The company focuses on the discovery and development of small molecule antimicrobials and other therapeutics for unmet medical needs through the application of its innovative Genetic Chemistry platform. Genetic Chemistry is defining a new paradigm for drug discovery, offering significant technical and economic advantages, as well as expediency in product development. Their most advanced lead is an aminoglycoside antibiotic that addresses the rapidly emerging resistant gram-negative hospital infection market. SelectX Pharmaceuticals recently secured an $8.00M Series B investment on 23 January 2004, with backing from Inventages, Techno Venture Management, Boston University Technology Development Fund. The company operates in the Biotechnology, Health Care, and Pharmaceutical industries. With its cutting-edge technology and focus on addressing critical medical needs, the company presents an intriguing opportunity for venture capital investment.

Taxonomy: biopharmaceutical, antimicrobials, therapeutics, small molecule, drug discovery, Genetic Chemistry, aminoglycoside antibiotic, resistant gram-negative infections, hospital infections, unmet medical needs, innovation, biomedical research, pharmaceutical industry

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $8.00M 3 Techno Venture Management, Boston University Technology Development Fund 23 Jan 2004
Venture Round Unknown 1 Techno Venture Management 01 Jan 2002

SelectX Pharmaceuticals Alternatives & Competitors

SelectX Pharmaceuticals vs

Elevating molecular pathology for genetic insights with advanced sequencing and innovative bioinform...

Series C
201-500 employees
Biopharma, Biotechnology
SelectX Pharmaceuticals vs

Premier life science service provider

Post Ipo Equity
1860 employees
Biotechnology, Pharmaceutical
SelectX Pharmaceuticals vs

Making molecules that matter

5 employees
Biotechnology

FAQ About SelectX Pharmaceuticals

SelectX Pharmaceuticals is a biopharmaceutical company that focuses on the discovery and development of small molecule antimicrobials and other therapeutics for unmet medical needs through the application of its innovative Genetic Chemistry platform. The company’s most advanced lead is an aminogl...
SelectX Pharmaceuticals was founded in 2002.
SelectX Pharmaceuticals is headquartered in Worcester, United States.
SelectX Pharmaceuticals operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
SelectX Pharmaceuticals has approximately 6 employees.
SelectX Pharmaceuticals has completed 2 funding rounds, raising a total of $8.00M. The latest funding stage is Series B.
Top alternatives and competitors to SelectX Pharmaceuticals include ArcherDX, Pharmaron, New England Discovery Partners (NEDP), Venatorx Pharmaceuticals, Inc., Apex Molecular Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SelectX Pharmaceuticals and ArcherDX are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors SelectX Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy